124 related articles for article (PubMed ID: 9636544)
1. ABO incompatible kidney transplantation on triple therapy compared with quadruple therapy.
Aikawa A; Ohara T; Hasegawa A; Yamashita M; Hadano T; Shindo M; Mizuiri T; Fushimi T; Sakai K; Hirayama N; Arai K; Tajima E
Transplant Proc; 1998 Jun; 30(4):1337-8. PubMed ID: 9636544
[No Abstract] [Full Text] [Related]
2. Tacrolimus therapy for ABO-incompatible kidney transplantation.
Takahashi K; Saito K; Sonda K; Nakagawa Y; Katagiri A; Tomita Y; Tanigawa T; Takeda M
Transplant Proc; 1998 Jun; 30(4):1219-20. PubMed ID: 9636495
[No Abstract] [Full Text] [Related]
3. ABO-incompatible kidney transplantation in a single-center trial.
Takahashi K; Yagisawa T; Sonda K; Kawaguchi H; Yamaguchi Y; Toma H; Agishi T; Ota K
Transplant Proc; 1993 Feb; 25(1 Pt 1):271-3. PubMed ID: 8438297
[No Abstract] [Full Text] [Related]
4. Quadruple immunosuppressive therapy with low-dose cyclosporine provides superior kidney transplant outcome using grafts of non-heart-beating uncontrolled cadavers.
Shiroki R; Hoshinaga K; Tsukiashi Y; Higuchi T; Izumitani M; Horiba M; Naide Y
Transplant Proc; 1997 Dec; 29(8):3571-3. PubMed ID: 9414841
[No Abstract] [Full Text] [Related]
5. Association between anti-thymocyte globulin administration and cytomegalic virus infection and/or CMV disease in cadaveric renal allograft recipients.
Siu CW; Chan TM; Li FK; Choy BY; Lui SL; Lo CY; Tang S; Lo WK; Lai KN
Transplant Proc; 2000 Nov; 32(7):1932-4. PubMed ID: 11120007
[No Abstract] [Full Text] [Related]
6. Low incidence of acute rejection in kidney grafts treated with initial quadruple therapy: a retrospective analysis comparing two ATGs.
Civati G; Minetti E; Busnach G; Perego A; Brando B; Broggi ML; Sansalone V; Forti D
Transplant Proc; 1998 Jun; 30(4):1343-5. PubMed ID: 9636546
[No Abstract] [Full Text] [Related]
7. Quadruple immunotherapy will promise excellent graft survival in cadaveric renal transplants using cardiac arrest donor grafts.
Hoshinaga K; Shiroki R; Higuchi T; Horiba Y; Yanaoka M; Naide Y
Transplant Proc; 1996 Jun; 28(3):1591-3. PubMed ID: 8658798
[No Abstract] [Full Text] [Related]
8. Incidence of cytomegalovirus disease in renal transplantation without antilymphocyte induction: is prophylaxis necessary?
Smith SR; Butterly DW; Conlon PJ; Harland RC; Emovon OE
Transplant Proc; 1998 Aug; 30(5):2097-9. PubMed ID: 9723404
[No Abstract] [Full Text] [Related]
9. Successful renal transplantation in presensitized recipients with double-filtration plasmapheresis and 15-deoxyspergualin.
Miura S; Okazaki H; Sato T; Amada N; Sakurada M
Transplant Proc; 1997; 29(1-2):350-1. PubMed ID: 9123034
[No Abstract] [Full Text] [Related]
10. Intraoperative T-cell depletion prior to completion of anastomoses by high-dose single ATG bolus as a new approach to improve long-term results after kidney transplantation.
Kaden J; May G; Strobelt V; Groth J; Müller P
Transplant Proc; 1997; 29(1-2):344-7. PubMed ID: 9123032
[No Abstract] [Full Text] [Related]
11. Risk factors of acute tacrolimus nephrotoxicity in renal allografts.
Shimizu T; Tanabe K; Tokumoto T; Ishikawa N; Shimmura H; Oshima T; Toma H; Yamaguchi Y
Transplant Proc; 2000 Nov; 32(7):1914-6. PubMed ID: 11119998
[No Abstract] [Full Text] [Related]
12. Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience.
Tanabe K; Ishikawa N; Tokumoto T; Takahashi K; Kanematsu A; Kitani R; Fuchinoue S; Oshima T; Yagisawa T; Toma H
Transplant Proc; 1998 Jun; 30(4):1224-6. PubMed ID: 9636497
[No Abstract] [Full Text] [Related]
13. Immunologic low-responder in ABO-incompatible renal transplant recipients explored by donor-specific platelet transfusion.
Ishibashi M; Oshida M; Kurata Y; Kokado Y; Takahara S; Kyo M; Ikoma F
Transplant Proc; 1998 Aug; 30(5):2298-9. PubMed ID: 9723480
[No Abstract] [Full Text] [Related]
14. Role of immunosuppressive drugs in the development of tissue-invasive cytomegalovirus infection in renal transplant recipients.
Kuypers DR; Evenepoel P; Maes BD; Coosemans W; Pirenne J; Vanrenterghem YF
Transplant Proc; 2002 Jun; 34(4):1164-70. PubMed ID: 12072305
[No Abstract] [Full Text] [Related]
15. Prospective randomized study of quadruple versus triple therapy in long-term kidney allografts.
Fruchaud G; Buisson C; Abbou C; Desvaux D; Baron C; Benmaadi A; Chopin D; Bourgeon B; Dahmane D; Rostoker G; Weil B; Lang P
Transplant Proc; 1996 Oct; 28(5):2819. PubMed ID: 8908077
[No Abstract] [Full Text] [Related]
16. Excellent long-term survival of low-risk, first renal allografts using cyclosporine/azathioprine double therapy.
Faull RJ; Bannister KM; Russ GR; Mathew TH; Clarkson AR
Transplant Proc; 1999; 31(1-2):1155-6. PubMed ID: 10083516
[No Abstract] [Full Text] [Related]
17. Intraoperative high-dose anti-T-lymphocyte globulin bolus in addition to triple-drug therapy improves kidney graft survival.
Kaden J; May G; Müller P; Groth J; Strobelt V; Eger E; Wohlfahrt L
Transplant Proc; 1995 Feb; 27(1):1060-1. PubMed ID: 7878804
[No Abstract] [Full Text] [Related]
18. Further study of deoxyspergualin prophylaxis in living related renal transplantation.
Okazaki H; Sato T; Amada N
Transplant Proc; 1993 Feb; 25(1 Pt 1):772-3. PubMed ID: 8438475
[No Abstract] [Full Text] [Related]
19. Does cyclosporine influence the outcome in patients with acute tubular necrosis after renal transplantation.
Ritz M; Botha J; Pontin AR; Pascoe MD; Kahn D
Transplant Proc; 1999; 31(1-2):303. PubMed ID: 10083117
[No Abstract] [Full Text] [Related]
20. Long-term results and risk factors of quadruple immunosuppression in renal transplantation.
Hiesse C; Kriaa F; Eschwege P; Boubenider S; Marchand S; Benoit G; Charpentier B
Transplant Proc; 1999; 31(1-2):1111-2. PubMed ID: 10083496
[No Abstract] [Full Text] [Related]
[Next] [New Search]
